Richmond pharmaceutical company Phlow Corp. is looking to raise up to $50 million in outside funding, according to a Securities and Exchange Commission filing.
Phlow has so far raised $24.2 million from 11 investors toward a Series B round, according to the early September filing. The round puts Phlow’s pre-money valuation at $230 million, according to PitchBook.
We’ve reached out to Phlow for comment and will update this post when we hear back.
Phlow, co-founded in early 2020 by Eric Edwards…
